Why coverage is so uneven
Many employer plans specifically exclude drugs prescribed for weight loss, as a category, regardless of medical necessity. That exclusion sits in the plan design, not with the insurer, so appealing on clinical grounds often will not move it.
The same molecule may be covered for a different indication. Semaglutide prescribed for type 2 diabetes is frequently covered where the same drug prescribed for obesity is not, and additional approved indications — cardiovascular risk reduction, obstructive sleep apnoea — have created further coverage routes.
This is why the exact diagnosis code on the prescription can determine whether you pay $25 or $1,300, and why it is worth asking your prescriber what they are coding.
Find out what your plan actually says
Do not rely on a customer service phone call alone. Ask for the formulary document and the plan's written policy on anti-obesity medication.
- Is there a categorical exclusion for weight loss drugs?
- Which specific products are on the formulary, and at what tier?
- Is prior authorisation required, and what criteria must be documented?
- Is there a step therapy requirement — a cheaper drug you must try first?
- Is there a documented participation requirement, such as a lifestyle programme?
- Is there a quantity limit or an annual maximum?
Prior authorisation, realistically
Prior authorisation typically requires your prescriber to document your BMI, any qualifying comorbid conditions, and often a history of attempted weight management. Incomplete documentation is the most common reason for denial, and it is fixable.
If you are denied, request the denial in writing with the specific reason. You have appeal rights, including an external review by an independent party in most circumstances. A meaningful share of appeals succeed, and prescribers' offices often have staff who do this routinely.
Medicare and Medicaid
Medicare Part D has historically been prohibited by statute from covering drugs used for weight loss, which is why Medicare beneficiaries have frequently been unable to get these medications for obesity alone. Coverage has been possible where the drug is prescribed for another approved indication.
This is an area of active policy change. A Medicare GLP-1 Bridge arrangement has been described by several academic health systems as making these medications available to eligible Part D members at around $50 a month. Michigan Medicine has published a detail worth knowing if that applies to you: that the $50 monthly payment does not count toward the annual Medicare prescription drug spending cap, which changes the arithmetic on your total yearly outlay.
Because this is moving, confirm the current position for your specific plan year with your plan directly rather than relying on any summary, including this one.
Medicaid coverage varies by state, with some states covering anti-obesity medication and others not.
Manufacturer savings programmes
Both manufacturers run savings cards that can substantially reduce copays for people with commercial insurance. These almost always exclude anyone with government insurance, including Medicare, Medicaid and TRICARE.
Separately, both run direct cash-pay channels for people without coverage, at prices well below list. If you have no coverage, price those before assuming a telehealth subscription is the cheaper route.
HSA and FSA
Prescription medication for a diagnosed medical condition is generally a qualifying medical expense, which means an HSA or FSA can usually be used for the medication itself.
Weight loss programmes are treated differently. The IRS position is that expenses for weight loss are qualifying only where the treatment is for a specific disease diagnosed by a physician — obesity included — rather than for general health. In practice a letter of medical necessity from your prescriber is often what makes the difference.
Telehealth membership fees are the grey area. Some administrators accept them as qualifying medical care, others do not. Ask your plan administrator before you assume, and keep the itemised receipts either way — a bundled charge that does not separate medication from membership is harder to substantiate.
If you are paying cash
Price the same medication at several pharmacies, including discount card prices, before accepting a provider's bundled figure. Prices for identical products vary more than most people expect.
And check whether the telehealth provider requires you to buy the medication through them. Some do, which removes your ability to shop the medication separately — a restriction that can quietly cost more than the membership fee saves.